de Witte, Moniek A <br/><br/>
TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Aug 2008 
 - 2563-71 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1550-6606 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.181.4.2563  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Animals<br/>Antigens, Viral, Tumor--biosynthesis<br/>Clone Cells<br/>Immunotherapy, Adoptive--methods<br/>Influenza A virus--immunology<br/>Lymphocyte Activation--genetics<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Prostatic Neoplasms--genetics<br/>Receptors, Antigen, T-Cell--administration & dosage<br/>Simian virus 40--immunology<br/>T-Lymphocytes--immunology<br/>Transduction, Genetic--methods<br/>Vaccinia--immunology